{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:38:13Z","timestamp":1793234293333,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to correlate resistance mutations of extended spectrum beta-lactamases (ESBL) and AmpC beta-lactamases and virulence factors (VF) with 30-day mortality in patients treated with either piperacillin-tazobactam or carbapenems. A post-hoc analysis on 123 patients with ceftriaxone-resistant<jats:italic>Escherichia coli<\/jats:italic>and<jats:italic>Klebsiella pneumoniae<\/jats:italic>bacteremia treated empirically with piperacillin-tazobactam and carbapenems was performed. Beta-lactamase resistance mutations and VF were identified by whole genome sequencing (WGS). The primary endpoint was 30-day mortality. Multivariate analyses were performed using logistic regression. WGS showed diverse multilocus sequence types (MLST) in 43\u2009<jats:italic>K. pneumoniae<\/jats:italic>strains, while ST131 predominated in<jats:italic>E. coli<\/jats:italic>strains (57\/80). CTX-M was most commonly detected (76\/80 [95%] of<jats:italic>E. coli<\/jats:italic>; 39\/43 [91%] of<jats:italic>K pneumoniae<\/jats:italic>.), followed by OXA (53\/80 [66%] of<jats:italic>E. coli<\/jats:italic>; 34\/43 [79%] of<jats:italic>K. pneumoniae<\/jats:italic>). A significant correlation was found between the number of genes encoding third-generation cephalosporin-resistant beta-lactamases and 30-day mortality (p\u2009=\u20090.045). The positive association was not significant after controlling for empiric carbapenem, Pitt score 3 and<jats:italic>K. pneumoniae<\/jats:italic>(OR 2.43, P\u2009=\u20090.073). None of the VF was associated with 30-day mortality. No association was found between 30-day mortality and any ESBL and AmpC beta-lactamases or VF when piperacillin-tazobactam or carbapenems were given. No significant association between 30-day mortality and active empiric therapy was found.<\/jats:p>","DOI":"10.1038\/s41598-018-31081-6","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T14:08:47Z","timestamp":1534774127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia"],"prefix":"10.1038","volume":"8","author":[{"given":"Shi Thong","family":"Heng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-2861","authenticated-orcid":false,"given":"Swaine L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua G. X.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tat Ming","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"31081_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","volume":"32","author":"System, N. N. I. S.","year":"2004","unstructured":"System, N. N. I. S. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 32, 470\u2013485 (2004).","journal-title":"Am J Infect Control."},{"key":"31081_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","volume":"14","author":"R Canto\u0144","year":"2008","unstructured":"Canto\u0144, R. et al. Prevalence and spread of extended-spectrum \u03b2 -lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14, 144\u2013153 (2008).","journal-title":"Clin. Microbiol. Infect."},{"key":"31081_CR3","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1128\/AAC.00971-12","volume":"57","author":"W-H Sheng","year":"2013","unstructured":"Sheng, W.-H., Badal, R. E. & Hsueh, P.-R. Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trend. Antimicrob. agents chemotherapy 57, 2981\u20132988 (2013).","journal-title":"Antimicrob. agents chemotherapy"},{"key":"31081_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson, D. L. & Bonomo, R. A. Extended-Spectrum beta-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18, 657\u2013686 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"31081_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"P Bradford","year":"2001","unstructured":"Bradford, P. Extended spectrum betalactamase in the 21 century: characterization, epidemiology, and detection of this impor- tant resistant threat. Clin. Microbiol Rev 14, 933\u2013951 (2001).","journal-title":"Clin. Microbiol Rev"},{"key":"31081_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.8.4.557","volume":"8","author":"DM Livermore","year":"1995","unstructured":"Livermore, D. M. Beta-Lactamases in laboratory and clinical resistance. Clin. microbiology reviews 8, 557\u201384 (1995).","journal-title":"Clin. microbiology reviews"},{"issue":"Suppl 1","key":"31081_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-0691.2007.01867.x","volume":"14","author":"GM Rossolini","year":"2008","unstructured":"Rossolini, G. M., D\u2019Andrea, M. M. & Mugnaioli, C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. microbiology infection: official publication Eur. Soc. Clin. Microbiol. Infect. Dis 14(Suppl 1), 33\u201341 (2008).","journal-title":"Clin. microbiology infection: official publication Eur. Soc. Clin. Microbiol. Infect. Dis"},{"key":"31081_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2009.08.019","volume":"66","author":"TY Tan","year":"2010","unstructured":"Tan, T. Y., Ng, L. S. Y., He, J. & Hsu, L. Y. CTX-M and ampC beta-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore. Diagn. microbiology infectious disease 66, 210\u2013213 (2010).","journal-title":"Diagn. microbiology infectious disease"},{"key":"31081_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","volume":"27","author":"M-H Nicolas-Chanoine","year":"2014","unstructured":"Nicolas-Chanoine, M.-H., Bertrand, X. & Madec, J.-Y. Escherichia coli ST131, an intriguing clonal group. Clin. microbiology reviews 27, 543\u2013574 (2014).","journal-title":"Clin. microbiology reviews"},{"key":"31081_CR10","first-page":"1","volume":"4","author":"JR Johnson","year":"2017","unstructured":"Johnson, J. R., Porter, S., Thuras, P. & Castanheira, M. The pandemic H30 subclone of sequence type 131 (ST131) as the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011-2012). Open Forum Infect. Dis. 4, 1\u201311 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"31081_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GAACB-L Jacoby","year":"2009","unstructured":"Jacoby, G. A. A. C. B.-L. Clin. Microbiol. Rev. 22, 161\u2013182 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"31081_CR12","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1128\/AAC.00143-10","volume":"54","author":"M Tumbarello","year":"2010","unstructured":"Tumbarello, M. et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta- lactamase production and inadequate initial antibiotic therapy. Antimicrob. Agents Chemother. 54, 4085\u20134091 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31081_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s15010-014-0670-9","volume":"42","author":"R Leistner","year":"2014","unstructured":"Leistner, R. et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infect. 42, 991\u2013997 (2014).","journal-title":"Infect."},{"key":"31081_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber, M. J. & Carmeli, Y. Mortality and delay in effective therapy associated with extended-spectrum \u03b2 -lactamase production in Enterobacteriaceae bacteraemia: A systematic review and meta-analysis. J. Antimicrob. Chemother. 60, 913\u2013920 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"31081_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2017.04.006","volume":"88","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. Bacteraemia due to AmpC beta-lactamase-producing Escherichia coli in hospitalized cancer patients: risk factors, antibiotic therapy, and outcomes. Diagn. microbiology infectious disease 88, 247\u2013251 (2017).","journal-title":"Diagn. microbiology infectious disease"},{"key":"31081_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/420816","volume":"39","author":"DL Paterson","year":"2004","unstructured":"Paterson, D. L. et al. Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -Lactamases. Clin. Infect. Dis. 39, 31\u201337 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"31081_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijantimicag.2012.06.004","volume":"40","author":"PNA Harris","year":"2018","unstructured":"Harris, P. N. A. & Ferguson, J. K. Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram- negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int. J. Antimicrob. Agents 40, 297\u2013305 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"31081_CR18","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann, P., Naas, T. & Poirel, L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. infectious diseases 17, 1791\u20131798 (2011).","journal-title":"Emerg. infectious diseases"},{"key":"31081_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy, K. K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet. Infect. diseases 10, 597\u2013602 (2010).","journal-title":"The Lancet. Infect. diseases"},{"key":"31081_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/cir273","volume":"53","author":"BA Rogers","year":"2011","unstructured":"Rogers, B. A., Aminzadeh, Z., Hayashi, Y. & Paterson, D. L. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin. infectious diseases: an official publication Infect. Dis. Soc. Am. 53, 49\u201356 (2011).","journal-title":"Clin. infectious diseases: an official publication Infect. Dis. Soc. Am."},{"key":"31081_CR21","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1128\/AAC.00607-13","volume":"57","author":"M McLaughlin","year":"2013","unstructured":"McLaughlin, M. et al. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob. Agents Chemother. 57, 5131\u20135133 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31081_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ja.2016.72","volume":"70","author":"MS Butler","year":"2017","unstructured":"Butler, M. S., Blaskovich, M. A. & Cooper, M. A. Antibiotics in the clinical pipeline at the end of 2015. The J. antibiotics 70, 3\u201324 (2017).","journal-title":"The J. antibiotics"},{"key":"31081_CR23","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","volume":"45","author":"KS Thomson","year":"2001","unstructured":"Thomson, K. S. & Moland, E. S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended- spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob. agents chemotherapy 45, 3548\u20133554 (2001).","journal-title":"Antimicrob. agents chemotherapy"},{"key":"31081_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0732-8893(94)90060-4","volume":"19","author":"G Bonfiglio","year":"1994","unstructured":"Bonfiglio, G. & Livermore, D. M. Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureus. Diagn. microbiology infectious disease 19, 163\u2013166 (1994).","journal-title":"Diagn. microbiology infectious disease"},{"key":"31081_CR25","doi-asserted-by":"publisher","first-page":"O831","DOI":"10.1111\/1469-0691.12677","volume":"20","author":"Y Harada","year":"2014","unstructured":"Harada, Y. et al. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clin. Microbiol. Infect. 20, O831\u2013O839 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"31081_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2003.11.007","volume":"49","author":"DS Burgess","year":"2004","unstructured":"Burgess, D. S. & Hall, R. Gn In vitro killing of parenteral beta-lactams against standard and high inocula of extended- spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae. Diagn. microbiology infectious disease 49, 41\u201346 (2004).","journal-title":"Diagn. microbiology infectious disease"},{"key":"31081_CR27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","volume":"60","author":"PD Tamma","year":"2015","unstructured":"Tamma, P. D. et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2 -lactamase bacteremia. Clin. Infect. Dis. 60, 1319\u20131325 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"31081_CR28","first-page":"1","volume":"11","author":"TM Ng","year":"2016","unstructured":"Ng, T. M. et al. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended- spectrum beta-lactamase-producing enterobacteriaceae. PLoS ONE 11, 1\u201311 (2016).","journal-title":"PLoS ONE"},{"key":"31081_CR29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1017\/ice.2015.101","volume":"36","author":"H Ofer-Friedman","year":"2015","unstructured":"Ofer-Friedman, H. et al. Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Infect. Control. Hosp. Epidemiol. 36, 981\u2013985 (2015).","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"31081_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.diagmicrobio.2014.07.006","volume":"80","author":"H-Y Tsai","year":"2014","unstructured":"Tsai, H.-Y. et al. Carbapenems and piperacillin\/tazobactam for the treatment of bacteremia caused by extended- spectrum beta-lactamase-producing Proteus mirabilis. Diagn. microbiology infectious disease 80, 222\u2013226 (2014).","journal-title":"Diagn. microbiology infectious disease"},{"key":"31081_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/cir790","volume":"54","author":"J Rodriguez-Bano","year":"2012","unstructured":"Rodriguez-Bano, J., Navarro, M. D., Retamar, P., Picon, E. & Pascual, A. beta-Lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin. infectious diseases: an official publication Infect. Dis. Soc. Am. 54, 167\u2013174 (2012).","journal-title":"Clin. infectious diseases: an official publication Infect. Dis. Soc. Am."},{"key":"31081_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-014-0541-9","volume":"16","author":"PN Harris","year":"2015","unstructured":"Harris, P. N. et al. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): Study protocol for a randomised controlled trial. Trials 16, 1\u20138 (2015).","journal-title":"Trials"},{"key":"31081_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","volume":"15","author":"PN Harris","year":"2015","unstructured":"Harris, P. N., Tambyah, P. A. & Paterson, D. L. Beta-lactam and beta-lactamase inhibitor combinations in the treatment of extended-spectrum \u03b2 -lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options? The Lancet Infect. Dis. 15, 475\u2013485 (2015).","journal-title":"The Lancet Infect. Dis."},{"key":"31081_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"EV Elm","year":"2007","unstructured":"Elm, E. V. et al. guidelines for reporting observational studies Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Br. Med. J. 335, 19\u201322 (2007).","journal-title":"Br. Med. J."},{"key":"31081_CR35","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush, K. & Jacoby, G. A. Updated functional classification of beta-lactamases. Antimicrob. agents chemotherapy 54, 969\u2013976 (2010).","journal-title":"Antimicrob. agents chemotherapy"},{"key":"31081_CR36","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1128\/AAC.50.4.1123-1129.2006","volume":"50","author":"GA Jacoby","year":"2006","unstructured":"Jacoby, G. A. Beta-lactamase nomenclature. Antimicrob. agents chemotherapy 50, 1123\u20131129 (2006).","journal-title":"Antimicrob. agents chemotherapy"},{"key":"31081_CR37","doi-asserted-by":"crossref","unstructured":"Zerbino, D. R. Using the Velvet de novo assembler for short-read sequencing technologies. Curr. Protoc. Bioinforma. (2010).","DOI":"10.1002\/0471250953.bi1105s31"},{"key":"31081_CR38","doi-asserted-by":"crossref","unstructured":"Gao, S., Nagarajan, N. & Sung, W. K. Opera: Reconstructing optimal genomic scaffolds with high-throughput paired-end sequences. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), vol. 6577 LNBI, 437\u2013451 (2011).","DOI":"10.1007\/978-3-642-20036-6_40"},{"issue":"LNBI","key":"31081_CR39","first-page":"314","volume":"7534","author":"S Gao","year":"2012","unstructured":"Gao, S., Bertrand, D. & Nagarajan, N. FinIS: Improved in silico finishing using an exact quadratic programming formulation. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 7534(LNBI), 314\u2013325 (2012).","journal-title":"In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)"},{"key":"31081_CR40","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T. Seemann","year":"2014","unstructured":"Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30(14), 2068\u20132069 (2014).","journal-title":"Bioinformatics"},{"key":"31081_CR41","doi-asserted-by":"publisher","first-page":"e104400","DOI":"10.1371\/journal.pone.0104400","volume":"9","author":"BM Forde","year":"2014","unstructured":"Forde, B. M. et al. The complete genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 clone. PloS one 9, e104400 (2014).","journal-title":"PloS one"},{"key":"31081_CR42","doi-asserted-by":"publisher","first-page":"e26578","DOI":"10.1371\/journal.pone.0026578","volume":"6","author":"M Totsika","year":"2011","unstructured":"Totsika, M. et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PloS one 6, e26578 (2011).","journal-title":"PloS one"},{"key":"31081_CR43","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma. (Oxford, England) 25, 1754\u20131760 (2009).","journal-title":"Bioinforma. (Oxford, England)"},{"key":"31081_CR44","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic acids research 40, 11189\u201311201 (2012).","journal-title":"Nucleic acids research"},{"key":"31081_CR45","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","volume":"28","author":"X Zheng","year":"2012","unstructured":"Zheng, X. et al. A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinforma. (Oxford, England) 28, 3326\u20133328 (2012).","journal-title":"Bioinforma. (Oxford, England)"},{"key":"31081_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/bioinformatics\/btg412","volume":"20","author":"E. Paradis","year":"2004","unstructured":"Paradis, E., Claude, J. & Strimmer, K. APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20(2), 289\u2013290 (2004).","journal-title":"Bioinformatics"},{"key":"31081_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/2041-210X.12628","volume":"8","author":"G Yu","year":"2017","unstructured":"Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T.-Y. ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28\u201336 (2017).","journal-title":"Methods Ecol. Evol."},{"key":"31081_CR48","doi-asserted-by":"crossref","unstructured":"Inouye, M. et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Medicine 6(11) (2014).","DOI":"10.1186\/s13073-014-0090-6"},{"key":"31081_CR49","doi-asserted-by":"crossref","unstructured":"Gupta, S. K. et al. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob. agents chemotherapy 58, 212\u2013220 (2014).","DOI":"10.1128\/AAC.01310-13"},{"key":"31081_CR50","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/nar\/gkv1239","volume":"44","author":"L Chen","year":"2016","unstructured":"Chen, L., Zheng, D., Liu, B., Yang, J. & Jin, Q. VFDB 2016: hierarchical and refined dataset for big data analysis\u201310 years on. Nucleic acids research 44, 694\u20137 (2016).","journal-title":"Nucleic acids research"},{"key":"31081_CR51","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1128\/IAI.00372-06","volume":"75","author":"MS Lawlor","year":"2007","unstructured":"Lawlor, M. S., O\u2019connor, C. & Miller, V. L. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect. immunity 75, 1463\u20131472 (2007).","journal-title":"Infect. immunity"},{"key":"31081_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jinf.2013.04.006","volume":"67","author":"J Rodr\u00b4\u0131guez-Ban\u02dco","year":"2013","unstructured":"Rodr\u00edguez-Ba\u00f1o, J. et al. Outcome of bacteraemia due to extended-spectrum \u03b2 -lactamase-producing Escherichia coli: Impact of microbiological determinants. J. Infect. 67, 27\u201334 (2013).","journal-title":"J. Infect."},{"key":"31081_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10096-010-1048-2","volume":"30","author":"U-I Wu","year":"2011","unstructured":"Wu, U.-I., Wang, J.-L., Chen, W.-C., Chang, S.-C. & Chen, Y.-C. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur. journal clinical microbiology & infectious diseases: official publication Eur. Soc. Clin. Microbiol. 30, 33\u201339 (2011).","journal-title":"Eur. journal clinical microbiology & infectious diseases: official publication Eur. Soc. Clin. Microbiol."},{"key":"31081_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1469-0691.2007.01685.x","volume":"13","author":"GS Miguel","year":"2007","unstructured":"Miguel, G. S. et al. Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases. Clin. microbiology infection: official publication Eur. Soc. Clin. Microbiol. Infect. Dis. 13, 532\u2013538 (2007).","journal-title":"Clin. microbiology infection: official publication Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"31081_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","volume":"352","author":"GA Jacoby","year":"2005","unstructured":"Jacoby, G. A. & Munoz-price, L. S. The New Beta-lactamases. The New Engl. J. Medicine 352, 380\u2013391 (2005).","journal-title":"The New Engl. J. Medicine"},{"key":"31081_CR56","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1073\/pnas.1501049112","volume":"112","author":"KE Holt","year":"2015","unstructured":"Holt, K. E. et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. United States Am. 112, 3574\u201381 (2015).","journal-title":"Proc. Natl. Acad. Sci. United States Am."},{"key":"31081_CR57","doi-asserted-by":"crossref","unstructured":"Long, S. W. et al. Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Kleb- siella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307. mBio 8, 00489\u201317 (2017).","DOI":"10.1128\/mBio.00489-17"},{"key":"31081_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkv346","volume":"71","author":"PN Harris","year":"2016","unstructured":"Harris, P. N. et al. Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: A systematic review with meta-analysis. J. Antimicrob. Chemother. 71, 296\u2013306 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"31081_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4161\/21505594.2014.991234","volume":"6","author":"M Mora-Rillo","year":"2015","unstructured":"Mora-Rillo, M. et al. Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia. Virulence 6, 93\u2013100 (2015).","journal-title":"Virulence"},{"key":"31081_CR60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s100960050483","volume":"19","author":"TA Hekker","year":"2000","unstructured":"Hekker, T. A. et al. Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur. journal clinical microbiology & infectious diseases: official publication Eur. Soc. Clin. Microbiol. 19, 312\u2013316 (2000).","journal-title":"Eur. journal clinical microbiology & infectious diseases: official publication Eur. Soc. Clin. Microbiol."},{"key":"31081_CR61","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1399-3062.2011.00618.x","volume":"13","author":"F Bert","year":"2011","unstructured":"Bert, F. et al. Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients. Transpl. infectious disease: an official journal Transplantation Soc. 13, 359\u2013365 (2011).","journal-title":"Transpl. infectious disease: an official journal Transplantation Soc."},{"key":"31081_CR62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13756-017-0256-2","volume":"6","author":"X Zheng","year":"2017","unstructured":"Zheng, X., Wang, J.-F., Xu, W.-L., Xu, J. & Hu, J. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob. resistance infection control 6, 102 (2017).","journal-title":"Antimicrob. resistance infection control"},{"key":"31081_CR63","doi-asserted-by":"crossref","unstructured":"Beceiro, A., Toma\u015b, M. & Bou, G. Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? (2013).","DOI":"10.1128\/CMR.00059-12"},{"key":"31081_CR64","doi-asserted-by":"crossref","unstructured":"Lefort, A. et al. Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia (2011).","DOI":"10.1128\/JCM.01902-10"},{"key":"31081_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.01512-08","volume":"54","author":"L Poirel","year":"2010","unstructured":"Poirel, L., Naas, T. & Nordmann, P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54, 24\u201338 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31081_CR66","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1128\/AAC.01677-07","volume":"52","author":"CR Bethel","year":"2008","unstructured":"Bethel, C. R. et al. Inhibition of OXA-1 beta-lactamase by penems. Antimicrob. Agents Chemother. 52, 3135\u20133143 (2008).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31081-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31081-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31081-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:27:14Z","timestamp":1751804834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31081-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31081"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31081-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12785"}}